SCHEMBL3688710

SCHEMBL3688710

C/C(=C/c1ccc(C(=O)O)s1)c1cc2c(cc1C)C(C)(C)CCC2(C)C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 20/20 1.00
▸ RXRB P28702 14/20 1.00
▸ RXRG P48443 14/20 1.00
▸ RARB P10826 13/20 1.00
▸ RARG P13631 12/20 1.00
▸ RARA P10276 8/20 0.73
▸ MEN1 O00255 1/20 0.49
▸ CYP26A1 O43174 1/20 0.49
▸ ABCB11 O95342 1/20 0.49
▸ ESR1 P03372 1/20 0.49
▸ PGR P06401 1/20 0.49
▸ HTR1A P08908 1/20 0.49
▸ ADRA2A P08913 1/20 0.49
▸ ADORA3 P0DMS8 1/20 0.49
▸ CHRM1 P11229 1/20 0.49
▸ DRD1 P21728 1/20 0.49
▸ TBXA2R P21731 1/20 0.49
▸ SLC6A2 P23975 1/20 0.49
▸ ADRA1A P35348 1/20 0.49
▸ OPRM1 P35372 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3688713 1.00 RXRA (1.00) RXRARXRBRXRGRARBRARG
SCHEMBL3688709 1.00 RXRA (1.00) RXRARXRBRXRGRARBRARG
SCHEMBL10937274 0.87 RXRA (0.77) RXRARXRBRXRGRARBRARG
SCHEMBL10937270 0.87 RXRA (0.77) RXRARXRBRXRGRARBRARG
SCHEMBL7219495 0.85 RXRA (0.74) RXRARXRBRXRGRARBRARG
SCHEMBL7219497 0.85 RXRA (0.74) RXRARXRBRXRGRARBRARG
SCHEMBL6263315 0.85 RXRA (0.74) RXRARXRBRXRGRARBRARG
SCHEMBL6263321 0.85 RXRA (0.74) RXRARXRBRXRGRARBRARG
SCHEMBL5929415 0.80 RXRA (1.00) RXRARXRBRXRGRARBRARG
SCHEMBL9128385 0.79 RXRA (1.00) RXRARXRBRXRGRARBRARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1461028-A4 TREATMENT FOR AGE-RELATED MACULAR DEGENERATION UNIV CALIFORNIA (US) 2007-07-25 — — EP claimed
WO-2004098506-A2 TREATMENT FOR AGE-RELATED MACULAR DEGENERATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2004-11-18 — — WO claimed
EP-1461028-A2 TREATMENT FOR AGE-RELATED MACULAR DEGENERATION The Regent of the University of California (US) 2004-09-29 — — EP claimed
US-20030229062-A1 Treatments for age-related macular degeneration (AMD) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2003-12-11 — — US claimed
US-20030162758-A1 Treatment for age-related macular degeneration (AMD) REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE 2003-08-28 — — US claimed
WO-2003049685-A2 TREATMENT FOR AGE-RELATED MACULAR DEGENERATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2003-06-19 — — WO claimed
US-20100047330-A1 TREATMENT FOR DARK ADAPTATION THE REGENTS OF THE UNIVERSTIY OF CALIFORNIA 2010-02-25 — — US disclosed
US-7470660-B2 Treatment for dark adaptation THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-12-30 — — US disclosed
US-7470659-B2 Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-12-30 — — US disclosed
EP-1461028-A4 TREATMENT FOR AGE-RELATED MACULAR DEGENERATION UNIV CALIFORNIA (US) 2007-07-25 — — EP disclosed
US-20050282750-A1 Treatment for dark adaptation THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2005-12-22 — — US disclosed
WO-2005091909-A2 METHODS TO INCREASE REVERSE CHOLESTEROL TRANSPORT IN THE RETINAL PIGMENT EPITHELIUM (RPE) AND BRUCH’S MEMBRANE (BM) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-10-06 — — WO disclosed
US-20040266663-A1 Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and bruch's membrane (BM) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2004-12-30 — — US disclosed
WO-2004098506-A2 TREATMENT FOR AGE-RELATED MACULAR DEGENERATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2004-11-18 — — WO disclosed
EP-1461028-A2 TREATMENT FOR AGE-RELATED MACULAR DEGENERATION The Regent of the University of California (US) 2004-09-29 — — EP disclosed
US-20030229062-A1 Treatments for age-related macular degeneration (AMD) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2003-12-11 — — US disclosed
US-20030162758-A1 Treatment for age-related macular degeneration (AMD) REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE 2003-08-28 — — US disclosed
WO-2003049685-A2 TREATMENT FOR AGE-RELATED MACULAR DEGENERATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2003-06-19 — — WO disclosed
Send feedback